About MITRO

Company Profile

Management Team

Evolution

News

North American Twin Cities Trip | A Successful Conclusion, MITRO's Globalization Layout Opens a New Chapter!

2025-06-27 15:47

Following the BIO 2025 International Biotechnology Convention (Boston, USA) and the SNMMI 2025 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (New Orleans, USA), MITRO returned home with valuable industry insights and strong relationships with global partners, marking a significant step forward in its globalization efforts.

This trip was not only a showcase and exchange of cutting-edge technologies but also a crucial milestone for MITRO in deepening global connections and expanding international collaborations. This participation further highlights MITRO's role as a globalized nuclear medicine CRDMO partner of key value. By deeply integrating with leading industry forces, we will continue to integrate international technical resources and domestic innovation advantages, accelerating the construction of a full-chain capability covering the research, development, production, and clinical transformation of radiopharmaceuticals, providing more efficient and reliable solutions for global partners.

At the BIO Convention held in Boston, MITRO's booth attracted industry professionals from around the world. We engaged in extensive and in-depth exchanges with leading global biopharmaceutical companies, research institutions, and potential partners. MITRO's deep cultivation of the nuclear medicine field for over a decade has accumulated radioisotope labeling technology and molecular imaging technology capabilities, committed to providing efficient and advanced one-stop services for global drug development.

Subsequently, the team traveled to New Orleans to participate in SNMMI, a top-tier global event in nuclear medicine and molecular imaging. This platform, which brings together leading international experts, provided MITRO with a valuable opportunity to deeply integrate into the global industrial ecosystem. During the four-day conference, MITRO actively engaged in multi-faceted dialogues with international experts and innovative institutions, sharing cutting-edge innovative practices and unique insights from China's nuclear medicine ecosystem, and deeply participating in strategic discussions on the future development of the industry. MITRO's extensive experience and advanced technical services garnered widespread attention and high recognition from international colleagues.

With the successful conclusion of this North American two-city trip, MITRO will continue to deepen its technological accumulation and enhance its service capabilities. We look forward to working with more global partners to jointly promote the advancement of radiopharmaceuticals and molecular imaging technologies, accelerating the availability of innovative therapies to patients worldwide, and contributing MITRO's strength to the cause of human health!

Thank you to all industry colleagues and partners who visited MITRO's booth and engaged in discussions with us during BIO2025 and SNMMI2025! Your attention and support are the inexhaustible driving force behind MITRO's progress. For those who were unable to attend, please feel free to contact us through our official channels.